Back to Search
Start Over
Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome
- Source :
- Romanian Journal of Internal Medicine, Vol 60, Iss 1, Pp 56-65 (2022)
- Publication Year :
- 2022
- Publisher :
- Sciendo, 2022.
-
Abstract
- Introduction. The aim was to evaluate the effect of therapeutic plasma exchange (TPE) and eculizumab on hematological and renal survival in atypical hemolytic uremic syndrome (aHUS), and additionally, to examine the reliability of discontinuation of eculizumab treatment.
Details
- Language :
- English
- ISSN :
- 2501062X
- Volume :
- 60
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Romanian Journal of Internal Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.1db47431634ff3adb8491159edd2c2
- Document Type :
- article
- Full Text :
- https://doi.org/10.2478/rjim-2021-0034